Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study

Purpose: To assess and compare the prevalence of medication nonadherence (MNA) (implementation and persistence) to immunosuppressants and co-medications in heart transplant recipients. Methods: MNA prevalence was assessed using the Basel Assessment of Adherence to Immunosuppressive Medications Scale...

Descripción completa

Detalles Bibliográficos
Autores: Helmy, R, Denhaerynck, K, Berben, L, Dobbels, F, Russell, CL, Roza, BD, De Geest, S, Crespo-Leiro, MG, Guppies, S, De Simone, P, Groenewoud, A, Kugler, C, Ohler, L, Van Cleemput, J, Poncelet, AJ, Sebbag, L, Michel, M, Bernard, A, Doesch, A, Livi, U, Potena, L, Brossa-Loidi, V, Segovia-Cubero, J, Almenar-Bonet, L, Saint-Gerons, CS, Mohacsi, P, Horvath, E, Riotto, C, Parry, G, Firouzi, A, Kozuszko, S, Haddad, H, Kaan, A, Fisher, G, Miller, T, Flattery, M, Ludrosky, K, Albert, N, Coleman, B, Trammell, J, Epstein, F, St Clair, K, Kao, A, Molina, M, Canales, KR, de Almeida, SS, Ayoub, AC, Barone, F, Harkess, M, Maddicks-Law, J, BRIGHT Study Team
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p3089
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3089
https://lirias.kuleuven.be/2350157&lang=en
Access Level:acceso abierto
Palabra clave:co-medications
cross-sectional
heart transplantation
immunosuppressants
international
medication adherence
id ES_dbf662b8969563bc3c7e4fef6f8535d9
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p3089
network_acronym_str ES
network_name_str España
repository_id_str
spelling Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT StudyHelmy, RDenhaerynck, KBerben, LDobbels, FRussell, CLRoza, BDDe Geest, SCrespo-Leiro, MGGuppies, SDe Simone, PGroenewoud, AKugler, COhler, LVan Cleemput, JPoncelet, AJSebbag, LMichel, MBernard, ADoesch, ALivi, UPotena, LBrossa-Loidi, VSegovia-Cubero, JAlmenar-Bonet, LSaint-Gerons, CSMohacsi, PHorvath, ERiotto, CParry, GFirouzi, AKozuszko, SHaddad, HKaan, AFisher, GMiller, TFlattery, MLudrosky, KAlbert, NColeman, BTrammell, JEpstein, FSt Clair, KKao, AMolina, MCanales, KRde Almeida, SSAyoub, ACBarone, FHarkess, MMaddicks-Law, JBRIGHT Study Teamco-medicationscross-sectionalheart transplantationimmunosuppressantsinternationalmedication adherencePurpose: To assess and compare the prevalence of medication nonadherence (MNA) (implementation and persistence) to immunosuppressants and co-medications in heart transplant recipients. Methods: MNA prevalence was assessed using the Basel Assessment of Adherence to Immunosuppressive Medications Scale (self-report) and compared using logistic regression in a 4-continent sample of 1397 heart transplant recipients from 36 heart transplant centers in 11 countries. Findings: MNA was significantly (alpha = 0.05) higher to co-medications than to immunosuppressants (taking nonadherence: 23.9% vs 17.3%; odds ratio [OR] = 1.5; 95% CI, 1.30-1.73; drug holiday: 5.7% vs 1.9%; OR = 3.17; 95% CI, 2.13-4.73; dose alteration: 3.8% vs 1.6%; OR = 2.46; 95% CI, 1.49-4.06; and discontinuation: 2.6% vs 0.5%; OR = 5.15; 95% CI, 2.36-11.20). (C) 2018 Elsevier Inc. All rights reserved.ELSEVIER2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3089https://lirias.kuleuven.be/2350157&lang=enCLINICAL THERAPEUTICSISSN: 01492918ISSNe: 1879114Xreponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p30892026-06-14T12:41:47Z
dc.title.none.fl_str_mv Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
title Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
spellingShingle Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
Helmy, R
co-medications
cross-sectional
heart transplantation
immunosuppressants
international
medication adherence
title_short Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
title_full Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
title_fullStr Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
title_full_unstemmed Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
title_sort Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
dc.creator.none.fl_str_mv Helmy, R
Denhaerynck, K
Berben, L
Dobbels, F
Russell, CL
Roza, BD
De Geest, S
Crespo-Leiro, MG
Guppies, S
De Simone, P
Groenewoud, A
Kugler, C
Ohler, L
Van Cleemput, J
Poncelet, AJ
Sebbag, L
Michel, M
Bernard, A
Doesch, A
Livi, U
Potena, L
Brossa-Loidi, V
Segovia-Cubero, J
Almenar-Bonet, L
Saint-Gerons, CS
Mohacsi, P
Horvath, E
Riotto, C
Parry, G
Firouzi, A
Kozuszko, S
Haddad, H
Kaan, A
Fisher, G
Miller, T
Flattery, M
Ludrosky, K
Albert, N
Coleman, B
Trammell, J
Epstein, F
St Clair, K
Kao, A
Molina, M
Canales, KR
de Almeida, SS
Ayoub, AC
Barone, F
Harkess, M
Maddicks-Law, J
BRIGHT Study Team
author Helmy, R
author_facet Helmy, R
Denhaerynck, K
Berben, L
Dobbels, F
Russell, CL
Roza, BD
De Geest, S
Crespo-Leiro, MG
Guppies, S
De Simone, P
Groenewoud, A
Kugler, C
Ohler, L
Van Cleemput, J
Poncelet, AJ
Sebbag, L
Michel, M
Bernard, A
Doesch, A
Livi, U
Potena, L
Brossa-Loidi, V
Segovia-Cubero, J
Almenar-Bonet, L
Saint-Gerons, CS
Mohacsi, P
Horvath, E
Riotto, C
Parry, G
Firouzi, A
Kozuszko, S
Haddad, H
Kaan, A
Fisher, G
Miller, T
Flattery, M
Ludrosky, K
Albert, N
Coleman, B
Trammell, J
Epstein, F
St Clair, K
Kao, A
Molina, M
Canales, KR
de Almeida, SS
Ayoub, AC
Barone, F
Harkess, M
Maddicks-Law, J
BRIGHT Study Team
author_role author
author2 Denhaerynck, K
Berben, L
Dobbels, F
Russell, CL
Roza, BD
De Geest, S
Crespo-Leiro, MG
Guppies, S
De Simone, P
Groenewoud, A
Kugler, C
Ohler, L
Van Cleemput, J
Poncelet, AJ
Sebbag, L
Michel, M
Bernard, A
Doesch, A
Livi, U
Potena, L
Brossa-Loidi, V
Segovia-Cubero, J
Almenar-Bonet, L
Saint-Gerons, CS
Mohacsi, P
Horvath, E
Riotto, C
Parry, G
Firouzi, A
Kozuszko, S
Haddad, H
Kaan, A
Fisher, G
Miller, T
Flattery, M
Ludrosky, K
Albert, N
Coleman, B
Trammell, J
Epstein, F
St Clair, K
Kao, A
Molina, M
Canales, KR
de Almeida, SS
Ayoub, AC
Barone, F
Harkess, M
Maddicks-Law, J
BRIGHT Study Team
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv co-medications
cross-sectional
heart transplantation
immunosuppressants
international
medication adherence
topic co-medications
cross-sectional
heart transplantation
immunosuppressants
international
medication adherence
description Purpose: To assess and compare the prevalence of medication nonadherence (MNA) (implementation and persistence) to immunosuppressants and co-medications in heart transplant recipients. Methods: MNA prevalence was assessed using the Basel Assessment of Adherence to Immunosuppressive Medications Scale (self-report) and compared using logistic regression in a 4-continent sample of 1397 heart transplant recipients from 36 heart transplant centers in 11 countries. Findings: MNA was significantly (alpha = 0.05) higher to co-medications than to immunosuppressants (taking nonadherence: 23.9% vs 17.3%; odds ratio [OR] = 1.5; 95% CI, 1.30-1.73; drug holiday: 5.7% vs 1.9%; OR = 3.17; 95% CI, 2.13-4.73; dose alteration: 3.8% vs 1.6%; OR = 2.46; 95% CI, 1.49-4.06; and discontinuation: 2.6% vs 0.5%; OR = 5.15; 95% CI, 2.36-11.20). (C) 2018 Elsevier Inc. All rights reserved.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3089
https://lirias.kuleuven.be/2350157&lang=en
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3089
https://lirias.kuleuven.be/2350157&lang=en
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER
publisher.none.fl_str_mv ELSEVIER
dc.source.none.fl_str_mv CLINICAL THERAPEUTICS
ISSN: 01492918
ISSNe: 1879114X
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421724891611136
score 15.812429